WHO says US$700 million raised thus far for COVID-19 vaccines initiative for poor


HARARE, Zimbabwe: Worldwide donors have raised US$700 million – lower than half the goal – to buy future coronavirus vaccines for poor international locations in a world initiative to make sure eventual vaccines don’t go solely to wealthy international locations, a World Well being Group official mentioned on Thursday (Sep 10).

The COVAX Superior Market Dedication has an preliminary goal of US$2 billion to purchase the vaccines.

READ: Commentary: Vaccine politics could hamper a COVID-19 recovery

“As much as right now, what has been mobilised thus far is US$700 million … So there’s an excessive amount of work to be finished to diversify the potential sources of funding,” Matshidiso Moeti, Africa regional director for the WHO, informed an internet press briefing.

COVAX is co-led by the GAVI Vaccine Alliance, the WHO and the CEPI Coalition for Epidemic Preparedness Improvements. Its purpose is to ship 2 billion doses of efficient, authorised COVID-19 vaccines by the top of 2021.

READ: AstraZeneca says should know if COVID-19 vaccine works by year-end if trials resume

READ: US, European COVID-19 vaccine developers pledge to uphold testing rigour

At the very least eight African international locations, together with South Africa, Gabon, Namibia and Equatorial Guinea had agreed to self-finance entry to the vaccine, Moeti mentioned.

The Africa Centres for Illness Management and Prevention mentioned final month the continent had began to slowly “bend the curve” of COVID-19 infections as measures like mask-wearing and social distancing sluggish the unfold of the pandemic.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Obtain our app or subscribe to our Telegram channel for the most recent updates on the coronavirus outbreak: https://cna.asia/telegram


Please enter your comment!
Please enter your name here